Blog, News, Companies, blood glucose meters, oral, Nasal, transdermal, insulin,type 2, pancreatic islet cells, Macular Edema, Ulcers, continuous glucose monitoring, HbA1c, hemoglobin A1C, oral anti-diabetic agent, data management system, Hypoglycemia, glucagon, therapeutic vaccine, peripheral neuropathy, Neuropathic pain, diabetes mellitus, type 1, foot ulcers, test strip, glycemic control, nephropathy, resistant, sensitizers, foot infections, sensor, retinopathy, non-invasive monitor...
August 21, 2007 – Medtronic, Inc. (NYSE: MDT) announced an exclusive United States agreement with LifeScan, Inc., a Johnson & Johnson (NYSE: JNJ) company, to distribute and co-market new blood glucose meters to be developed by LifeScan for Medtronic Diabetes patients.
